CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease

[1]  Linda Chang,et al.  Effects of APOE ε4, age, and HIV on glial metabolites and cognitive deficits , 2014, Neurology.

[2]  T. Nagasawa.  CXC chemokine ligand 12 (CXCL12) and its receptor CXCR4 , 2014, Journal of Molecular Medicine.

[3]  I. Grant,et al.  A Concise Panel of Biomarkers Identifies Neurocognitive Functioning Changes in HIV-Infected Individuals , 2013, Journal of Neuroimmune Pharmacology.

[4]  R. Ellis,et al.  Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection , 2013, AIDS.

[5]  Caroline Rae,et al.  HIV, Vascular and Aging Injuries in the Brain of Clinically Stable HIV-Infected Adults: A 1H MRS Study , 2013, PloS one.

[6]  Masoumeh Sikaroodi,et al.  Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[7]  Jintanat Ananworanich,et al.  Central nervous system viral invasion and inflammation during acute HIV infection. , 2012, The Journal of infectious diseases.

[8]  H. Uno,et al.  Monocyte Activation Markers in Cerebrospinal Fluid Associated With Impaired Neurocognitive Testing in Advanced HIV Infection , 2012, Journal of acquired immune deficiency syndromes.

[9]  J. Allsop,et al.  Alterations in Cerebrospinal Fluid Chemokines Are Associated With Maraviroc Exposure and In Vivo Metabolites Measurable by Magnetic Resonance Spectroscopy , 2012, HIV clinical trials.

[10]  Terry L. Jernigan,et al.  Clinical factors related to brain structure in HIV: the CHARTER study , 2011, Journal of NeuroVirology.

[11]  Jianhui Zhong,et al.  Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment , 2011, AIDS.

[12]  Michael J. Taylor,et al.  Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals , 2011, Journal of NeuroVirology.

[13]  Michael J. Taylor,et al.  Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individuals , 2011, Journal of clinical and experimental neuropsychology.

[14]  E. Daar.  Faculty Opinions recommendation of HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. , 2011 .

[15]  Michael J. Taylor,et al.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy , 2010, Neurology.

[16]  M. Gill,et al.  Neurologic disease burden in treated HIV/AIDS predicts survival , 2010, Neurology.

[17]  N. Karin.  The multiple faces of CXCL12 (SDF‐1α) in the regulation of immunity during health and disease , 2010, Journal of leukocyte biology.

[18]  D. Fuchs,et al.  Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection , 2010, AIDS research and therapy.

[19]  C. Power,et al.  Regulation of Lentivirus Neurovirulence by Lipopolysaccharide Conditioning: Suppression of CXCL10 in the Brain by IL-10 , 2009, The Journal of Immunology.

[20]  Wei Zheng,et al.  Relationship Between Changes in Brain MRI and 1H-MRS, Severity of Chronic Liver Damage, and Recovery After Liver Transplantation , 2009, Experimental biology and medicine.

[21]  J. Allsop,et al.  Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study. , 2008, Journal of hepatology.

[22]  K. Fenton.  Changing epidemiology of HIV/AIDS in the United States: implications for enhancing and promoting HIV testing strategies. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J. Becker,et al.  Updated research nosology for HIV-associated neurocognitive disorders , 2007, Neurology.

[24]  Robert E. Lenkinski,et al.  Recent advances in magnetic resonance neurospectroscopy , 2007, Neurotherapeutics.

[25]  J. Brenchley,et al.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Retrovirology.

[26]  Klaas Nicolay,et al.  1H MR spectroscopy of the brain: absolute quantification of metabolites. , 2006, Radiology.

[27]  Linda Chang,et al.  Regional patterns of brain metabolites in AIDS dementia complex , 2004, NeuroImage.

[28]  A. Wu,et al.  Neurocognitive performance and quality of life in patients with HIV infection. , 2003, AIDS research and human retroviruses.

[29]  Linda Chang,et al.  Antiretroviral Treatment Alters Relationship between Mcp-1 and Neurometabolites in HIV Patients , 2003, Antiviral therapy.

[30]  A. Häkkinen,et al.  Proton Spectroscopic Imaging Shows Abnormalities in Glial and Neuronal Cell Pools in Frontal Lobe Epilepsy , 2001, Epilepsia.

[31]  S. Provencher.  Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.

[32]  K. Dietz,et al.  Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude , 2001, Acta Neuropathologica.

[33]  K. Ruxrungtham,et al.  Magnetic resonance spectroscopy of the brain in neurologically asymptomatic HIV-infected patients. , 2000, Magnetic resonance imaging.

[34]  H. Pfister,et al.  Identification of a T cell chemotactic factor in the cerebrospinal fluid of HIV-1-infected individuals as interferon-γ inducible protein 10 , 1999, Journal of Neuroimmunology.

[35]  W. Kelder,et al.  β‐Chemokines MCP‐1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus–associated dementia , 1998 .

[36]  J. Sodroski,et al.  The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.

[37]  I Grant,et al.  Neuropsychological impairment in human immunodeficiency virus‐infection: implications for employment. HNRC Group. HIV Neurobehavioral Research Center. , 1994, Psychosomatic medicine.

[38]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[39]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .